12029 results
Keyword Sildenafil Alter Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,
, Revision: 16, Authorised, Last updated: 01/06/2023
Sildenafil Actavis Male Urogenital … Sildenafil Actavis … Sildenafil Actavis, INN sildenafil EMA/482355/2014 EMEA/H/C/001090 … -
List item
Human medicine European public assessment report (EPAR): Sildenafil Teva
sildenafil, Erectile Dysfunction
Date of authorisation: 30/11/2009,, Revision: 17, Authorised, Last updated: 04/07/2022
Sildenafil Teva Male Urogenital Diseases Genital … Sildenafil Teva … Sildenafil Teva, INN sildenafil 7 Westferry Circus … -
List item
Human medicine European public assessment report (EPAR): Sildenafil ratiopharm
sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009,, Revision: 19, Authorised, Last updated: 24/06/2022
Sildenafil ratiopharm Male Urogenital … Authorised sildenafil Overview This is a summary … assessment report (EPAR) for sildenafil. It explains how the The committee … -
List item
Withdrawn application: Sildenafil FGK
sildenafil, date of withdrawal: 19/07/2021, Initial authorisation, Last updated: 05/10/2021Sildenafil FGK: Withdrawn application … marketing authorisation of Sildenafil FGK sildenafil) FGK Representative Service … marketing authorisation of Sildenafil FGK for the treatment of … -
List item
Herbal medicinal product: Melaleucae aetheroleum
Melaleuca alternifolia (Maiden and Betche) Cheel, Tea-tree oil, F: Assessment finalised, Last updated: 02/08/2023branches of the trees Melaleuca alternifolia Cheel, M. linariifolia Smith … Tea tree oil Melaleuca alternifolia (Maiden and Betch) Cheel … branches of the trees Melaleuca alternifolia Cheel, M. linariifolia Smith … -
List item
Human medicine European public assessment report (EPAR): Revatio
sildenafil, Hypertension, Pulmonary
Date of authorisation: 28/10/2005, Revision: 49, Authorised, Last updated: 21/03/2023medicine. active substance sildenafil. How is Revatio used? Revatio … active substance in Revatio, sildenafil, belongs to a group of medicines … vessels. In patients with PAH, sildenafil widens the blood vessels … -
List item
Human medicine European public assessment report (EPAR): Viagra (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 13/09/1998, Revision: 45, Authorised, Last updated: 18/09/2023Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. It is available as tablets … active ingredient in Viagra, sildenafil, belongs to a group of medicines … -
List item
Human medicine European public assessment report (EPAR): Mysildecard
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016,, Revision: 7, Authorised, Last updated: 30/06/2023
Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. It is a ‘ A generic medicine … other medicines containing sildenafil should therefore be used … -
List item
Human medicine European public assessment report (EPAR): Granpidam
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 14/11/2016,, Revision: 8, Authorised, Last updated: 11/04/2023
sildenafil … Granpidam, INN: sildenafil EMA/622310/2016 EMEA/H/C/004289 … for the public Granpidam sildenafil This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Vizarsin
sildenafil, Erectile Dysfunction
Date of authorisation: 21/09/2009,, Revision: 19, Authorised, Last updated: 24/02/2023
Authorised sildenafil Overview This is a summary … medicine. active substance sildenafil. It is available as film-coated … active ingredient in Vizarsin, sildenafil, belongs to a group of medicines … -
List item
Human medicine European public assessment report (EPAR): Patrex
sildenafil, Erectile Dysfunction
Date of authorisation: 15/09/1998, Revision: 4, Withdrawn, Last updated: 18/08/2005Withdrawn sildenafil Overview The marketing authorisation … Public statement on Patrex (sildenafil): Non-renewal of the marketing … PUBLIC STATEMENT ON PATREX (sildenafil) NON-RENEWAL OF THE … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Revatio, sildenafil
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: EMEA-000671-PIP01-09-M10, Route(s) of administration: Oral use, Intravenous use, Pharmaceutical form(s): Film-coated tablet, Powder for oral solution, Solution for injection
Decision date: 03/01/2019, Last updated: 21/09/2021, Compliance check: V, 20/09/2019Revatio Active substance sildenafil Therapeutic area Other Decision … Revatio Revatio sildenafil sildenafil sildenafil … -
List item
Withdrawn application: Viagra
sildenafil, date of withdrawal: 19/11/2008, Post-authorisation, Last updated: 20/11/2008contains the active substance sildenafil. It is available as tablets … active ingredient in Viagra, sildenafil, belongs to a group of medicines … International Nonproprietary Name: Sildenafil citrate Procedure No … -
List item
Orphan designation: sildenafil for: Treatment of congenital diaphragmatic hernia
Date of designation: 20/06/2017, Positive, Last updated: 17/07/2017BV, the Netherlands, for sildenafil for the treatment of congenital … medicine expected to work? Sildenafil is expected to be given during … becoming too high after birth. Sildenafil is already authorised in … -
List item
Orphan designation: sildenafil citrate for: treatment of postcardiotomy right ventricular failure
Date of designation: 26/11/2010, Positive, Last updated: 23/10/2018Limited, United Kingdom, for sildenafil citrate for the treatment … medicine expected to work? Sildenafil is a medicine that has been … the heart to the lungs). Sildenafil works by blocking an enzyme … -
List item
Orphan designation: sildenafil citrate for: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Date of designation: 12/12/2003, Expired, Last updated: 19/01/2016Sildenafil citrate (Revatio) is authorised … condition, the existence or not of alternative methods of diagnosis, prevention … ORPHAN DESIGNATION OF sildenafil citrate for the treatment … -
List item
Clinical efficacy and safety: blood products (including biotech alternatives)
Last updated: 11/02/2016products (including biotech alternatives) … products (including biotech alternatives) …
-
List item
Promoting the authorisation of alternatives to antimicrobial veterinary medicinal products in the EU - Scientific guideline
Last updated: 26/07/2021omoting the authorisation of alternatives to antimicrobial veterinary … omoting the authorisation of alternatives to antimicrobial veterinary … promoting the authorisation of alternatives to antimicrobial veterinary …
-
List item
Press release: Acipimox only to be used as additional or alternative treatment to reduce high triglyceride levels
CMDh, Last updated: 20/12/2013be used as additional or alternative treatment to reduce high … only as an additional or alternative treatment in type IIb and … role as an additional or alternative treatment to reduce triglycerides … -
List item
Press release: PRAC recommends using acipimox only as additional or alternative treatment to lower high triglyceride levels
PRAC, Last updated: 08/11/2013acipimox only as additional or alternative treatment to lower high triglyceride … acipimox only as additional or alternative treatment to lower high triglyceride … acipimox only as additional or alternative treatment to lower high triglyceride … -
List item
Replacement of rabbit pyrogen testing by an alternative test for plasma derived medicinal products - Scientific guideline
Last updated: 23/04/2009rabbit pyrogen testing by an alternative test for plasma derived medicinal … rabbit pyrogen testing by an alternative test for plasma derived medicinal … RABBIT PYROGEN TESTING BY AN ALTERNATIVE TEST FOR PLASMA DERIVED MEDICINAL …
-
List item
Press release: Pfizer withdraws its application to change the marketing authorisation for Viagra 50 mg (sildenafil) from prescription-only to non-prescription
Last updated: 20/11/2008authorisation for Viagra 50 mg (sildenafil) from prescription-only to … for the medicine Viagra (sildenafil) 50 mg film-coated tablets … authorisation for Viagra 50 mg (sildenafil) from prescription-only to … -
List item
Orphan designation: N-(tert-butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-[1,1'-biphenyl]-3-yl)oxy)benzenesulfonamide for: Treatment of pulmonary arterial hypertension
Date of designation: 22/02/2018, Positive, Last updated: 08/04/2020macitentan, riociguat, selexipag, sildenafil, tadalafil and treprostinil … given in combination with sildenafil, was more effective at reducing … reducing blood pressure than sildenafil alone. This assumption will … -
List item
Orphan designation: Ubenimex for: Treatment of pulmonary arterial hypertension
Date of designation: 21/03/2016, Positive, Last updated: 19/08/2019iloprost, macitentan, riociguat, sildenafil, tadalafil and treprostinil … more than another medicine, sildenafil. This assumption will need … condition; the existence of alternative methods of diagnosis, prevention … -
List item
Orphan designation: Ralinepag for: Treatment of pulmonary arterial hypertension
Date of designation: 11/01/2019, Positive, Last updated: 13/02/2023macitentan, riociguat, selexipag, sildenafil, tadalafil and treprostinil … condition; the existence of alternative methods of diagnosis, prevention …